We are pleased to announce that our CEO/President Eiji Tahara
has contributed an article about our antibody drug development to
FUJIFILM Wako Pure Chemical Corporation’s blog.
The article provides comprehensive insights into our development
process, covering everything from the project’s background to the
technical features of our antibody therapeutics, explaining complex
scientific content in an accessible manner.

Publication Date: April 25, 2025
Language: Japanese

→ Read the full article here